Community Feed

Sun Pharma–Organon: An Indian Giant’s $11.75 Billion Global Power Move.

• India's largest overseas pharma acquisition: The announced deal is a landmark cross-border transaction for an Indian pharmaceutical company.
• A stronger global presence: The combined business is expected to generate approximately $12.4 billion in annual revenue, according to the companies' announcement.
• A major push into women's health: Organon's portfolio strengthens Sun Pharma's presence in women's healthcare, alongside general medicines and biosimilars.
• +2 more points

Deep, an investor in Mumbai · 22 hours ago

Buy-Side Mandate: $2M+ EBITDA Businesses in California & the West Coast

West Coast, USA

Kautilya is currently advising a U.S.-based searcher seeking to acquire established operating businesses with $2M+ in EBITDA, primarily across California and the broader West Coast. The search is focused on businesses with meaningful recurring or repeat revenue, strong operating fundamentals, stable cash flows, and durable customer relationships. While there is particular interest in professional services, real estate services, trade and vocational education, and other service-oriented businesses, the mandate remains industry-flexible, and we welcome opportunities across a broad range of sectors. We are actively engaging with business owners, brokers, and intermediaries to identify both marketed and off-market opportunities that align with this mandate. If you are representing a business that may be a fit or are aware of an opportunity that meets these criteria we would welcome the opportunity to connect and discuss further.

Aditya Gada, a member · 22 hours ago

Free 1:1 for first-time searchers — SBA loan process and diligence

Offering, SBA loans, buyer-side diligence

Closed two SBA-financed acquisitions over the past three years. Happy to walk anyone early in a search through the loan process, red flags I wish I had caught sooner, and what to actually ask sellers in diligence. No fee, just paying it forward.

Marcus Webb, an intermediary in Chicago, IL, USA · last month

Lower middle market PE: sourcing and value creation panel

Chicago, IL

A panel of LMM private equity investors on how they source proprietary deal flow, what they look for in a first platform investment, and where they focus post-close value creation in year one.

Priya Shah, an investor from Wharton in Denver, CO, USA · last month

Starting a company vs. buying one — the question I always ask

One of the best questions to ask someone looking to buy a company: what makes you more interested in buying vs. starting from scratch? Curious how others here think about it, especially sub-$1M EBITDA deals.

Alex Rivera, a searcher from University of Virginia in Tampa, FL, USA · last month

Deal structuring: debt, seller notes, and earnouts

Zoom (link on RSVP)

How the pieces fit together in an acquisition: the debt stack, seller notes and where they sit in the standby order, earnouts, and outside equity.

Priya Shah, an investor from Wharton in Denver, CO, USA · last month

Search fund deal sourcing intern

Jaan Capital, Austin, TX, USA, Remote

Work directly with the founder to identify, contact, and qualify acquisition targets. Learn the search fund model by doing the work: cold outreach, broker relationships, deal qualification.

Marcus Webb, an intermediary in Chicago, IL, USA · last month

Niche industrial parts supplier — $990K EBITDA

Manufacturing, SBA eligible

Supplier of custom equipment and spare parts for a small niche of large industrial equipment. Only one other company in the space. Seller retiring, LOI signed.

Priya Shah, an investor from Wharton in Denver, CO, USA · last month